LAURA SEIPT: Open Payments
NPI 1144818600 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,556 in 104 payments from 36 companies in 2025. Trend: 2023 $2,022 · 2024 $1,954 · 2025 $2,556
Food & beverage: $2,366Education: $190
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $210 |
| ABBVIE INC. | 6 | $195 |
| Merck Sharp & Dohme LLC | 7 | $195 |
| SEAGEN INC. | 2 | $190 |
| Novartis Pharmaceuticals Corporation | 8 | $168 |
| Janssen Biotech, Inc. | 6 | $140 |
| Celgene Corporation | 9 | $139 |
| Ipsen Biopharmaceuticals, Inc | 3 | $138 |
| PFIZER INC. | 6 | $133 |
| Geron Corporation | 4 | $93 |
Products named: OPDIVO, KEYTRUDA, REBLOZYL, Onivyde, EMRELIS, RYTELO, KISQALI, Nubeqa.
Industry payments across SC — which companies pay providers there.
